serw-MX  [xml]  

 DeCS Categories

D04 Polycyclic Compounds .
D04.345 Macrocyclic Compounds .
D04.345.566 Peptides, Cyclic .
D04.345.566.802 Streptogramins .
D04.345.566.802.875 Virginiamycin .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.641 Peptides, Cyclic .
D12.644.641.802 Streptogramins .
D12.644.641.802.875 Virginiamycin .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.875 Reproductive Control Agents .
D27.505.696.875.552 Fertility Agents .
D27.505.954 Therapeutic Uses .
D27.505.954.705 Reproductive Control Agents .
D27.505.954.705.552 Fertility Agents .
G05 Genetic Phenomena .
G05.285 Founder Effect .
HP1 Homeopathy .
HP1.007 Homeopathic Philosophy .
HP1.007.281 Pharmacodynamic Action of Homeopathic Remedy .
HP1.007.281.893 Rebound Effect .
SP4 Environmental Health .
SP4.011 Science .
SP4.011.087 Contamination .
SP4.011.087.718 Industrial Pollution .
SP4.011.087.718.439 Industry .
SP4.011.087.718.439.115 Foundry .
SP4.046 Occupational Health .
SP4.046.462 Industry .
SP4.046.462.798 Foundry .
SP5 Epidemiology and Biostatistics .
SP5.001 Epidemiology .
SP5.001.012 Epidemiologic Studies .
SP5.001.012.033 Epidemiology, Descriptive .
SP5. Population Characteristics .
SP5. Age Effect .
SP5.001.047 Uses of Epidemiology .
SP5.001.047.158 Effectiveness .
 Synonyms & Historicals
Founder Effect .
Effect, Founder .
Effects, Founder .
Founder Effects .
A phenomenon that is observed when a small subgroup of a larger POPULATION establishes itself as a separate and isolated entity. The subgroup's GENE POOL carries only a fraction of the genetic diversity of the parental population resulting in an increased frequency of certain diseases in the subgroup, especially those diseases known to be autosomal recessive. .
Foundry .
Age Effect .
The result of changes in the health status of individuals based on age, regardless of exposure conditions and birth cohort (age itself is a risk factor and is related to certain diseases in different conditions). .
Virginiamycin .
Antibiotic 899 .
Eskalin .
Founderguard .
Stajac .
Virgimycine .
Staphylomycin .
A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry. .
Fertility Agents .
Fertility Drugs .
Fertility Effect .
Fertility Effects .
Infertility Drugs .
Infertility Effect .
Infertility Effects .
Agents, Fertility .
Agents, Infertility .
Drugs, Fertility .
Drugs, Infertility .
Effect, Fertility .
Effect, Infertility .
Effects, Fertility .
Effects, Infertility .
Infertility Agents .
Drugs used to increase fertility or to treat infertility. .
Effectiveness .
Is a measure of the extent to which a specific intervention, procedure, regimen, or service, when deployed in the field in routine circumstaces, fulfills its objectives. .
Rebound Effect .
Paradoxical reaction of the organism to the primary (direct) effect of the medicine, producing opposite effect and increased after discontinuation or cessation of treatment. In homeopathy, it corresponds to the secondary (indirect) effect of the organism, used as curative response when the therapeutic similitude principle is applied. .